Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma

OBJECTIVE: To evaluate the effects of the concomitant use of proton pump inhibitors (PPIs) and/or antibiotics (Abs) on oncological outcomes in patients with advanced urothelial carcinoma. PATIENTS AND METHODS: We retrospectively evaluated 155 patients with advanced urothelial carcinoma who were trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuyama, Yoshiharu, Hatakeyama, Shingo, Numakura, Kazuyuki, Narita, Takuma, Tanaka, Toshikazu, Miura, Yuki, Sasaki, Daichi, Noro, Daisuke, Tokui, Noriko, Okamoto, Teppei, Yamamoto, Hayato, Narita, Shintaro, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Habuchi, Tomonori, Ohyama, Chikara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988833/
https://www.ncbi.nlm.nih.gov/pubmed/35474728
http://dx.doi.org/10.1002/bco2.118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988833/
https://www.ncbi.nlm.nih.gov/pubmed/35474728
http://dx.doi.org/10.1002/bco2.118

Ejemplares similares